$KDP

Keurig Dr Pepper Inc. (KDP): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Keurig Dr Pepper Inc. (KDP) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. kdp-20260810 0001418135 FALSE 0001418135 2026-08-10 2026-08-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

Original reporting
Published Aug 12, 2026, 12:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 12:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$KDP
Neutral
medium confidence
Mentioned
$KDP
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$KDPNeutralLow
01

Why it matters

The disclosure updates Keurig Dr Pepper’s board composition and Audit and Finance Committee membership effective August 14, 2026, with no stated operational or financial changes.

02

Market read

Governance update with limited immediate trading implications absent additional strategic or financial disclosures.

03

What to watch

If Alt’s background aligns with a known risk area (not provided here), the market may later reprice governance risk; monitor subsequent proxy disclosures for more detail.

Relevance 6/10Novelty 4/10Timing: effective August 14, 2026 (board/committee changes)

Background

This is an SEC Form 8-K (Item 5.02) reporting director/officer compensatory arrangements and committee assignments.

Company-level read

Ticker impact

$KDPNeutralMedium confidence
Context

Keurig Dr Pepper appointed Aaron Alt as an independent director and added him to the Audit and Finance Committee effective August 14, 2026.

Expected impact

Likely minimal near-term price impact; any reaction would be sentiment-driven and short-lived unless tied to broader strategy not disclosed here.

Evidence & confidence

The filing is an SEC 8-K describing director appointment and committee assignment, without guidance changes, financial datapoints, or material transactions.

Market effects

No sector-level implications disclosed; this is company-specific governance housekeeping.

None indicated.

None indicated.

Counterpoint

The appointment could reflect internal audit or finance oversight tightening, but the filing provides no rationale, so traders may overreact without additional context.

Key entities

  • Keurig Dr Pepper Inc.

    Nasdaq-listed company filing the 8-K describing a director appointment and committee assignment.

  • Aaron Alt

    Appointed independent member of the Board and member of the Audit and Finance Committee effective August 14, 2026.

  • Anthony Shoemaker

    Chief Legal Officer, General Counsel and Secretary signing the filing.

Related articles

$KDPMedAI 8/10

Here’s What KDP’s Q2 Earnings Reveal About the Coffee Business Nobody’s Watching

Keurig Dr Pepper (KDP) reported Q2 revenue up 75.57% YoY to $7.31B and adjusted EPS up 16.33% to $0.57, boosted by JDE Peet’s consolidation. U.S. Refreshment Beverages net sales rose 10%, while U.S. Coffee net sales fell 3.2% and operating income dropped 24.7% due to green coffee inflation and tariffs. KDP reaffirmed low-double-digit adjusted EPS growth and net sales guidance of $25.9B to $26.4B.

$KDPMed

Keurig Dr Pepper Inc. Q2 2026 Earnings Call Summary

Keurig Dr Pepper reported Q2 2026 results that exceeded expectations, citing double-digit U.S. Refreshment Beverages growth and day-one integration of JDE Peet's. Dr Pepper Zero Sugar grew 30% in retail sales and energy reached 9% market share. U.S. Coffee faced margin pressure from hedging and tariffs. KDP reaffirmed low double-digit EPS growth for 2026 and low-double-digit legacy growth at the high end of 4% to 6%.

$KDPMedAI 8/10

Keurig Dr Pepper Reaffirms Forecast On Strong Soda, Energy Drink Demand

Keurig Dr Pepper (KDP) kept its annual forecast after Q2 results beat analysts, supported by stronger soda and energy drink demand while its coffee business weakened. US Refreshment Beverages sales rose 10%, with gains in Dr Pepper Zero Sugar, Ghost and Electrolit. Net sales were $7.31B, up 75.6%, and adjusted EPS was 57 cents. 2026 guidance: $25.9B-$26.4B net sales and low double-digit EPS growth.

$KDPMedAI 8/10

Why Is Keurig Dr Pepper Stock Gaining Thursday? - Keurig Dr Pepper (NASDAQ:KDP)

Keurig Dr Pepper (NASDAQ:KDP) reported adjusted EPS of 57 cents, above the 54-cent consensus, and revenue of $7.31B vs $7.24B expected. GAAP net sales rose 75.6% year over year, largely from the JDE Peet’s acquisition. Segment results showed U.S. Refreshment up, U.S. Coffee down. Free cash flow was $714M. KDP reaffirmed 2026 revenue guidance of $25.9B to $26.4B.

$KDPMed

Keurig Dr Pepper maintains annual forecasts after quarterly results beat

Keurig Dr Pepper kept its annual forecasts after Q2 results beat expectations. According to LSEG, net sales rose 75.6% to $7.31B vs $7.24B expected, and adjusted profit was 57 cents per share vs 54 cents expected. The U.S. Refreshment Beverages division sales rose 10%. For 2026, it expects net sales of $25.9B to $26.4B and low-double-digit adjusted EPS growth.